6th Annual Cedars-Sinai Gastrointestinal Tumor Conference: Bringing the Future of Cancer Care to Our Patients Today
Hybrid Event
Apr 05, 2025
Los Angeles, California, USA
5 AMA PRA Category 1 Credits™ ...OVERVIEW
6th Annual Cedars-Sinai Gastrointestinal Tumor Conference: Bringing the Future of Cancer Care to Our Patients Today is organized by Cedars-Sinai Medical Center and will be held on Apr 05, 2025 at Cedars Sinai Medical Center Harvey Morse Conference Center South Tower, Los Angeles, California, United States of America.
Description:
The 6th Annual Cedars-Sinai Gastrointestinal Tumor Conference will provide concise and comprehensive updates on the most recent research and advances in therapy for gastrointestinal cancers. A stellar faculty has been assembled to share developments in precision medicine, research, and immunotherapeutic approaches to the treatment of cancers of the pancreas, liver, and gastricesophagus. Invited faculty will present a comprehensive bench to bedside review of immune therapy for GI malignancies, detail immune therapies for pancreatic cancer, and explore advances in biomarkers and immunotherapy in gastroesophageal cancers. Biomarker strategies for neuroendocrine and rare tumors will be presented and participants will also have an opportunity to review immune-related toxicities. Join your colleagues for this important half day educational activity that will enhance your understanding of GI cancers and provide you with valuable information to inform your clinical decision-making and treatment approaches for your patients.
Objectives:
- Analyze advances in biomarkers and therapies to evaluate and synthesize treatment options for patients with gastroesophageal cancers.
- Use AJCC or other appropriate staging in clinical practice, including the use of appropriate prognostic indicators and evidence based national guidelines for treatment planning
- Evaluate the basic science of immune therapy for GI malignancies and the implications for transfer from bench to bedside
- Increase knowledge of therapy for neuroendocrine tumors and biomarker identification of novel therapies
- Identify and implement optimal strategies for managing therapy related side effects and toxicities in patients treated with therapeutic agents
- Anticipate the needs, problems, and issues of cancer survivors and develop an individualized wellness plan in partnership with cancer survivors, their families and the healthcare team
KEY DATES
05 Apr, 2025
Event Start Date
05 Apr, 2025
Event End Date
ACCREDITATION & CREDITS
Accreditation
In support of improving patient care, Cedars-Sinai is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
AMA Credit Designation Statement
Cedars-Sinai designates this Live Activity for a maximum of 5.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Non-Physician AMA Attendance
Attendance credit will be provided to other healthcare professionals upon the fulfillment of attendance requirements. Participants should ensure in advance that their credentialing or licensing organization accepts AMA PRA Category 1 Credits™.
Maintenance of Certification (MOC) for Physicians: Successful completion of some CME activities, which includes participation in the evaluation component if required for the activity, may enable the participant to earn MOC points. As the CME activity provider, it is Cedars-Sinai’s responsibility to submit participant completion information to the ACCME for the purpose of granting earned MOC credit, provided the learner has completed the “Credit Reporting” steps indicated above in advance of the activity. If offered for this CME activity, MOC type and points that may be earned are indicated below.
American Board of Internal Medicine (ABIM) Part II MOC: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 5.00 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Credits
AMA PRA Category 1 Credit(s)™ (MD, DO) (5.00 hours), ABIM MOC Part 2 (5.00 hours), Non-Physician AMA Attendance (5.00 hours)
TARGET AUDIENCE
PhysicianPharmacistAdvanced Practice NurseClinical Nurse SpecialistsEndocrinologistsResearchersPain ManagementOncologistsRadiologistsResidentsOccupational TherapistsFamily MedicineNursesGastroenterologistsMedical GeneticistsLaboratory TechniciansNuclear Medicine PhysiciansPathologistsPalliative Medicine PhysicianMidwifeFellowsRadiation OncologistsSPECIALITIES
Endocrinology, Metabolism and DiabetesFamily MedicineInternal Medicine and General MedicineGastroenterologyMedical Genetics and GenomicsNuclear MedicineOncologyPain ManagementPathologyLaboratory MedicineRadiation OncologyRadiologyHospice and Palliative MedicineSUGGESTED HOTELS
CONFERENCE VENUE
Cedars Sinai Medical Center Harvey Morse Conference Center South Tower
Quick Links